Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review
Open Access
- 29 October 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (6) , 1-7
Abstract
Background: Cardiac amyloidosis, a progressive cardiac disease, results from the accumulation of undegraded proteinaceous substrates in the extracellular matrix of the heart. It may present as acute coronary syndrome (ACS); therefore, a clear distinction remains challenging in clinical practice. We describe a case of cardiac amyloidosis mimicking ACS.Case summary: A 72-year-old man experienced chest discomfort for 2 days. He gradually developed dyspnoea during the preceding month. Electrocardiogram (ECG) showed sinus rhythm with right bundle branch block and low voltage. Echocardiography revealed concentric left ventricular thickening, biatrial dilation, and preserved ejection fraction with predominantly left ventricular basal hypokinesis. Serial testing of the cardiac biomarkers showed persistently increased high-sensitive cardiac troponin T levels and normal serum creatine kinase myocardial band levels. He was diagnosed with ACS with haemodynamic stability. However, coronary angiography demonstrated non-obstructive coronary arteries. Furthermore, significant macroglossia and periorbital purpura were noticed. Laboratory investigations revealed elevated serum immunoglobulin free light chain (FLC) kappa and lambda levels with an increased FLC ratio. Histological analysis of the biopsied abdominal skin confirmed amyloidosis.Discussion: Cardiac amyloidosis often presents as restrictive cardiomyopathy. The usual symptoms include dyspnoea and peripheral oedema. Chest pain may manifest rarely, leading to misdiagnosis as coronary artery disease. Some findings suggestive of cardiac amyloidosis include clinical signs such as amyloid deposits, dyspnoea, low ECG voltage, and basal-predominant hypokinesis with relative apical sparing in echocardiography. Serum FLC test and abdominal skin biopsy can confirm the diagnosis of amyloidosis when a myocardial biopsy is not feasible.Keywords
This publication has 13 references indexed in Scilit:
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2017
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac AmyloidosisJACC: Heart Failure, 2014
- Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosisHeart, 2012
- Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2010
- Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosisThe American Journal of Medicine, 2005
- Primary, systemic amyloidosis and the dermatologist: Where classic skin lesions may provide the clue for early diagnosisDermatology Online Journal, 2005
- Cardiac Amyloidosis Presenting as Microvascular AnginaAngiology, 2001
- Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findingsThe American Journal of Cardiology, 2000
- Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotininEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995